Activest Wealth Management’s Phio Pharmaceuticals PHIO Stock Holding History

Activest Wealth Management’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9	Hold	9	–	–	﹤0.01%	1331
2026 Q1	$11	Hold	9	–	–	﹤0.01%	1216
2025 Q4	$9	Hold	9	–	–	﹤0.01%	1111
2025 Q3	$22	Hold	9	–	–	﹤0.01%	1118
2025 Q2	$21	Hold	9	–	–	﹤0.01%	1012
2025 Q1	$12	Hold	9	–	–	﹤0.01%	1024
2024 Q4	$16	Hold	9	–	–	﹤0.01%	857
2024 Q3	$31	Hold	9	–	–	﹤0.01%	544
2024 Q2	$57	Buy	+9	New	+$59	﹤0.01%	503

Other funds holding PHIO

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Activest Wealth Management's PHIO Position: Q2 2026 in Review

Activest Wealth Management held its Phio Pharmaceuticals (PHIO) position steady in Q2 2026 at 9 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #1331.

Activest Wealth Management first reported a position in PHIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $57 in Q2 2024. 2 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

Activest Wealth Management held 9 shares of Phio Pharmaceuticals worth $9 as of Q2 2026.
Activest Wealth Management left its Phio Pharmaceuticals share count unchanged in Q2 2026.
Phio Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1331 holding.
Activest Wealth Management first reported a position in Phio Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Phio Pharmaceuticals position peaked at $57 in Q2 2024.
2 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.